By Ahmed Aboulenein WASHINGTON, Dec 18 (Reuters) - Americans enrolled in Medicare will pay about 50% less out of pocket in ...

"The noninferior effect of tirzepatide as compared with dulaglutide on the primary cardiovascular outcome provides additional ...

Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment ...

Nxera Pharma, which recently announced a number of job cuts in Cambridge, is putting on a brave face after suffering another ...

Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces that Boehringer Ingelheim has informed the Company ...

Boehringer Ingelheim launched the first-ever Catvocacy Forum for the company, uniting veterinarians to elevate cat care ...

Emerging evidence hints that daily multivitamins might quietly help certain older adults keep their blood pressure in ...

Numab to receive milestone payment Boehringer Ingelheim has advanced its novel multi-specific antibody for retinal diseases resulting from a collaboration with Numab into preclinical development ...

Pets Date Night, Boehringer Ingelheim’s signature event, celebrates the special bond between pets and their families and ...

AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon ​to announce agreements ...

Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...

Informing patients about bariatric surgery is a comprehensive discussion, so aim to provide the most up-to-date information about both pre- and post-surgery expectations.